Phase 1 Non-Hodgkins Lymphoma Clinical Trials
3 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–3 of 3 trials
Recruiting
Phase 1
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
B-cell Non-Hodgkins Lymphoma (B-NHL)
Regeneron Pharmaceuticals91 enrolled20 locationsNCT05685173
Not Yet Recruiting
Phase 1
Safety of Immune Cells for Patients with Relapsed Leukaemia or Lymphoma after Chemotherapy
Acute Lymphoblastic LeukaemiaNon-Hodgkins LymphomaChronic Lymphocytic Leukaemia
Western Sydney Local Health District, Westmead Hospital20 enrolled11 locationsACTRN12619000079145
Recruiting
Phase 1
Safety of Immune Cells for Patients with Relapsed Leukaemia or Lymphoma after Bone Marrow Transplant
Acute Lymphoblastic LeukaemiaNon-Hodgkins LymphomaChronic Lymphocytic Leukaemia
Western Sydney Local Health District, Westmead Hospital20 enrolled3 locationsACTRN12617001579381